Corrigendum to "Obesity III: Obesogen assays: Limitations, strengths, and new directions" [Biochem. Pharmacol. 199 (2022) 115014].
Biochem Pharmacol
; 202: 115145, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35716579
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Biochem Pharmacol
Year:
2022
Document type:
Article